Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06687174 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Evaluate the Efficacy and Safety of MY008211A in Subjects with Primary Immunoglobulin a Nephropathy (IgAN)

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 18, 2024 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv2
  2. Study First Submitted
Efficacy and safety of MY008211A in IgAN patients
Trial Details
NCT Number NCT06687174
Lead Sponsor Wuhan Createrna Science and Technology Co., Ltd
Conditions
(from sponsor)		 IgA Nephropathy (IgAN)
Related terms Glomerulonephritis, IGA, Kidney Diseases
Enrollment 72 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov